ARCHIVES

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 26 No. 38 | October 20, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER

March 20, 1992

NTP Board Approves Four New Concepts

October 8, 1982

Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects

August 29, 2008

Sentinel Lymph Node Excision Has No Impact on Survival

August 26, 2011

Also in this 8-page issue: Tony Hunter, Raymond DuBois win AACR Landon prizes.

March 5, 2004

Four UICC Programs Available For International Research

July 10, 1981